Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bio-Rad Laboratories, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BIO
New York
3840
www.bio-rad.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bio-Rad Laboratories, Inc.
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
- Jun 29th, 2026 11:30 am
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- Jun 24th, 2026 1:30 pm
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
- Jun 22nd, 2026 4:04 pm
Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
- Jun 17th, 2026 2:30 pm
Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
- Jun 11th, 2026 4:30 am
Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas
- Jun 4th, 2026 5:00 am
Is Elliott’s Sartorius Push Altering The Investment Case For Bio-Rad Laboratories (BIO)?
- May 25th, 2026 5:11 am
Elliott Targets Bio-Rad After 70% Stock Collapse
- May 22nd, 2026 11:25 am
Stocks Settle Mixed as Iran War Remains Unresolved
- May 18th, 2026 2:35 pm
Stocks Pressured by a Rebound in Crude Prices and Bond Yields
- May 18th, 2026 9:25 am
Stocks Mixed as Crude Oil Prices and Bond Yields Fall
- May 18th, 2026 8:05 am
Sector Update: Healthcare Stocks Decline Pre-Bell Monday
- May 18th, 2026 7:18 am
Bio-Rad to Participate in Upcoming Investor Conferences
- May 8th, 2026 7:00 am
Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand Out
- May 5th, 2026 10:14 am
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- May 4th, 2026 1:30 pm
How The Biocon (NSEI:BIOCON) Story Is Shifting As Analysts Recut Growth And Risk Assumptions
- May 4th, 2026 12:12 pm
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
- May 4th, 2026 8:27 am
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects
- May 4th, 2026 7:15 am
Bio-Rad (BIO) Q1 2026 Earnings Transcript
- May 1st, 2026 10:28 am
Bio-Rad Laboratories, Inc. Q1 2026 Earnings Call Summary
- May 1st, 2026 6:30 am
Scroll